In vivo electroporation enhances the immunogenicity of an HIV-1 DNA vaccine candidate in healthy volunteers
about
A review of malaria vaccine clinical projects based on the WHO rainbow tableWhat you always needed to know about electroporation based DNA vaccinesCan immunotherapy be useful as a "functional cure" for infection with Human Immunodeficiency Virus-1?Vaccination with human papillomavirus pseudovirus-encapsidated plasmids targeted to skin using microneedlesDNA and protein co-immunization improves the magnitude and longevity of humoral immune responses in macaquesIntramuscular delivery of heterodimeric IL-15 DNA in macaques produces systemic levels of bioactive cytokine inducing proliferation of NK and T cellsEfficient vaccine against pandemic influenza: combining DNA vaccination and targeted delivery to MHC class II molecules.Phase 1 study of pandemic H1 DNA vaccine in healthy adultsHIV-1 vaccines: challenges and new perspectivesImmunologic responses to xenogeneic tyrosinase DNA vaccine administered by electroporation in patients with malignant melanomaNovel directions in HIV-1 vaccines revealed from clinical trialsVaccination with Gag, Vif, and Nef gene fragments affords partial control of viral replication after mucosal challenge with SIVmac239HIVIS-DNA or HIVISopt-DNA priming followed by CMDR vaccinia-based boosts induce both humoral and cellular murine immune responses to HIV.The influence of delivery vectors on HIV vaccine efficacyThe secreted lipoprotein, MPT83, of Mycobacterium tuberculosis is recognized during human tuberculosis and stimulates protective immunity in miceSafety and immunogenicity of DNA and MVA HIV-1 subtype C vaccine prime-boost regimens: a phase I randomised Trial in HIV-uninfected Indian volunteersMultivalent human papillomavirus l1 DNA vaccination utilizing electroporation.DNA vaccine delivered by a needle-free injection device improves potency of priming for antibody and CD8+ T-cell responses after rAd5 boost in a randomized clinical trialElectroporation as a method to induce myofiber regeneration and increase the engraftment of myogenic cells in skeletal muscles of primates.Immunotherapy against HPV16/18 generates potent TH1 and cytotoxic cellular immune responses.Synthetic consensus HIV-1 DNA induces potent cellular immune responses and synthesis of granzyme B, perforin in HIV infected individualsComparison of plasmid vaccine immunization schedules using intradermal in vivo electroporationHIV-DNA priming alters T cell responses to HIV-adenovirus vaccine even when responses to DNA are undetectable.HIV-DNA Given with or without Intradermal Electroporation Is Safe and Highly Immunogenic in Healthy Swedish HIV-1 DNA/MVA Vaccinees: A Phase I Randomized Trial.A Phase I Double Blind, Placebo-Controlled, Randomized Study of the Safety and Immunogenicity of Electroporated HIV DNA with or without Interleukin 12 in Prime-Boost Combinations with an Ad35 HIV Vaccine in Healthy HIV-Seronegative African Adults.Elucidating the Kinetics of Expression and Immune Cell Infiltration Resulting from Plasmid Gene Delivery Enhanced by Surface Dermal Electroporation.Enhanced Delivery and Potency of Self-Amplifying mRNA Vaccines by Electroporation in SituHIV DNA Vaccine: Stepwise Improvements Make a Difference.Superior induction of T cell responses to conserved HIV-1 regions by electroporated alphavirus replicon DNA compared to that with conventional plasmid DNA vaccine.Future directions in research, treatment and prevention of HPV-related squamous cell carcinoma of the head and neck.Vaccine-Induced Simian Immunodeficiency Virus-Specific CD8+ T-Cell Responses Focused on a Single Nef Epitope Select for Escape Variants Shortly after Infection.New prospects for a preventive HIV-1 vaccine.Intradermal DNA vaccination enhanced by low-current electroporation improves antigen expression and induces robust cellular and humoral immune responses.In vivo molecular imaging and histological analysis of changes induced by electric pulses used for plasmid DNA electrotransfer to the skin: a study in a dorsal window chamber in mice.Electroporation on microchips: the harmful effects of pH changes and scaling downA combination of intradermal jet-injection and electroporation overcomes in vivo dose restriction of DNA vaccines.DNA and virus particle vaccination protects against acquisition and confers control of viremia upon heterologous simian immunodeficiency virus challengeSafety and immunogenicity of DNA prime and modified vaccinia ankara virus-HIV subtype C vaccine boost in healthy adults.Clinical trial in healthy malaria-naïve adults to evaluate the safety, tolerability, immunogenicity and efficacy of MuStDO5, a five-gene, sporozoite/hepatic stage Plasmodium falciparum DNA vaccine combined with escalating dose human GM-CSF DNAIL-12 DNA as molecular vaccine adjuvant increases the cytotoxic T cell responses and breadth of humoral immune responses in SIV DNA vaccinated macaques
P2860
Q21034112-C8E7FC4A-C2F5-4553-983C-7FA6A3C6C9DFQ24602340-30DE5909-12C5-4EB6-A6DF-551B326C14D7Q26865388-C7A8C4E0-327A-433A-B934-00664E3F1D52Q27311290-96AC8D7D-0081-4AB9-8066-EDEDBF1C45A3Q27316075-021D4DFA-9B85-403B-A090-D432328AE064Q28652428-2254CB07-912C-457D-932E-133389FA793DQ30204348-80874889-1054-481F-B3C0-C5929A8A1CFCQ30373824-11E06082-E6BB-4889-9EEE-2E770AFF8139Q33577972-E384A669-D8C5-4061-B482-CF7F11376956Q33606137-D1441E0E-4028-4F40-B369-FD876082D5E5Q33645528-9D3B0597-5935-4C91-BD27-895CBA93DC5EQ33744109-DB9523DD-25B0-4C5A-95F6-A7FB761228ADQ33869332-F28BD023-4A88-4241-8438-B67C841872A9Q34077543-710DB830-1E47-4B77-89C7-9FF0012B9607Q34261521-3F3CD62A-59C2-46C9-861A-9DF01C7B4EEDQ34589611-6EB11E06-90FB-41A8-9FD0-DE7586B22438Q34639978-10947CB4-45F6-4C64-B89D-B7750A2FC880Q34663554-037F5DBB-24AD-4C6D-8EB9-5541E1931726Q34823922-8F3EBFEF-4E46-4668-B32D-FE33C258C470Q35049821-16973D70-CA01-4D7E-AF62-63CF95F4614AQ35153129-07A405D2-7573-49AA-AF04-7E9CDC24CF34Q35191236-23012733-BCF5-4242-AFBA-F6EF525A05C2Q35234257-68A56B00-4D5E-49C4-82B9-4B8D043EC6D4Q35677513-C8DBFCF7-09D1-4326-B6BD-D937B2935693Q35739841-5091F8A3-0C14-4997-B3B3-9541B67D4046Q35826661-A2F76E4C-FF5F-4A29-926A-079FD1BE458FQ35826688-33EE7B94-F979-444C-94B1-D13257F1C9F1Q35826742-A724C0E9-9195-4EF9-8F34-F5A10A165BA4Q35868091-F40B1FBA-0143-4FEA-A2A1-E25DE287E0B9Q36088069-3624A5D8-C12C-4AC1-AA6A-B92288CBEB5DQ36208138-20C45BE8-1396-4F38-A17C-196E385CFE28Q36223864-94DB9EEB-4AAD-4ECE-A496-D8EBB2F444A1Q36228884-EEC2F409-16A4-4252-9FAC-F08960A2A0C7Q36297880-2A247153-84E4-400E-BD62-DBF5B59A3C1CQ36367188-5744D260-7B95-4736-A74E-3B7DBEF50249Q36494079-3F048E9F-587B-481F-94BB-6C457689DED1Q36637349-FC93016C-5DE5-49E9-A7E9-5DD972D07EFEQ36668517-F1E5BD13-C25A-4DF5-A1E5-EC60647940E2Q36694820-55D32412-EC41-450F-B95F-2824FEC5590DQ36694836-38C94DE0-12F8-43CE-8FC7-BB9DF902E9FA
P2860
In vivo electroporation enhances the immunogenicity of an HIV-1 DNA vaccine candidate in healthy volunteers
description
2011 nî lūn-bûn
@nan
2011 թուականին հրատարակուած գիտական յօդուած
@hyw
2011 թվականին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
In vivo electroporation enhanc ...... andidate in healthy volunteers
@ast
In vivo electroporation enhanc ...... andidate in healthy volunteers
@en
In vivo electroporation enhanc ...... andidate in healthy volunteers
@nl
type
label
In vivo electroporation enhanc ...... andidate in healthy volunteers
@ast
In vivo electroporation enhanc ...... andidate in healthy volunteers
@en
In vivo electroporation enhanc ...... andidate in healthy volunteers
@nl
prefLabel
In vivo electroporation enhanc ...... andidate in healthy volunteers
@ast
In vivo electroporation enhanc ...... andidate in healthy volunteers
@en
In vivo electroporation enhanc ...... andidate in healthy volunteers
@nl
P2093
P2860
P3181
P1433
P1476
In vivo electroporation enhanc ...... andidate in healthy volunteers
@en
P2093
Arlene Hurley
Carol Smith
Claudia Schmidt
Daniel P Dugin
David D Ho
David F Gardiner
Dilbinder K Gill
Drew Hannaman
Hannah Cheeseman
Harriet H Park
P2860
P304
P3181
P356
10.1371/JOURNAL.PONE.0019252
P407
P577
2011-01-01T00:00:00Z